SCYX
SCYNEXIS INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$3.92
−0.51%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 24.98x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.58x
- Price / sales
- 2.03x
- Price / cash flow
- -2.93x
Enterprise value
- Enterprise value
- -$13.1M
- EV / sales
- -0.68x
- EV / EBITDA
- 1.28x
- EV / EBIT
- 0.58x
- Market cap
- $39.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026